Overview

• U.S. personal care firm's fiscal Q2 sales slightly beat analyst expectations, up 0.6% yr/yr

• Adjusted EPS for fiscal Q2 beat analyst expectations but declined from prior year

• Company reaffirmed full-year outlook for organic net sales, adjusted EPS and EBITDA

Outlook

• Edgewell reaffirms full-year outlook for organic net sales, adjusted EPS and adjusted EBITDA

• Company expects reported net sales to rise 0.8% to 3.8% for fiscal 2026

• Edgewell expects adjusted EPS of $1.70 to $2.10 for fiscal 2026

Result Drivers

• INNOVATION & BRAND MOMENTUM - Co said improved execution and innovation drove momentum in brands like Cremo, Hawaiian Tropic and Billie

• NORTH AMERICA WEAKNESS - Organic sales declined 4.8% in North America, mainly due to lower volumes in Wet Shave and Sun Care

• MARGIN PRESSURE - Gross margin fell due to core inflation, tariffs, unfavorable mix, and higher promotions, only partly offset by productivity savings

Company press release: ID:nPn6l12JSa

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q2 Sales	Slight Beat*	$519.50 mln	$515.05 mln (5 Analysts)
Q2 Adjusted EPS	Beat	$0.60	$0.45 (7 Analysts)
Q2 Adjusted Operating Income	Beat	$49.40 mln	$40.59 mln (5 Analysts)
Q2 Gross Profit		$216.90 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the personal products peer group is "buy."

• Wall Street's median 12-month price target for Edgewell Personal Care Co is $22.50, about 1.4% above its May 5 closing price of $22.83

• The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.